IL2 and miliary tuberculosis: Given that IL-12 and IL-2 similarly expand HMBPP-activated Vγ2Vδ2 T-cell clones but act via distinct mechanisms (20, 21), targetting these two powerful cytokines may provide a strategy to enhance antimicrobial Vγ2Vδ2 T cells responses to intervene in patients with multi-drug resistant and/or disseminated tuberculosis.